Skip to main content
# Title Research Year
11 Non-Metastatic Triple Negative Breast Cancer with Neuroendocrine Differentiation: Survival Parameters 2025
12 Predictive and Prognostic Significance of Serum Neuron Specific Enolase in Patients with Metastatic Non-Small Cell Lung Cancer Receiving Gefitinib: A Prospective Study from South Egypt Cancer Institute 2025
13 Predictive Factors for Site of Local and Systemic Recurrence in Breast Cancer Patients 2025
14 Role of immunohistochemistry in molecular classification, prognosis, and survival of colorectal cancer patients 2025
15 Prognostic significance of the tumor budding and tumor-infiltrating lymphocytes in survival of hepatocellular carcinoma patients 2024
16 Assessment of Response to Hormonal Therapy by Serum Ki-67 as a Biomarker in Non-metastatic Hormone Positive Breast Cancer 2024
17 Outcome of Anthracycline versus Taxane Based Regimens on Different Metastatic Sites in Breast Cancer 2024
18 prognostic significance of the tumor budding and tumor- infiltrating lymphocytes in survival of hepatocellular carcinoma patients 2024
19 Prognostic Value of Erythropoietin-Producing Hepatocellular Receptor A2 (Epha2) Serum Marker in Colorectal Cancer 2024
20 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line 2024